Skip to main content

Table 5 Criteria to assess the risk for bias

From: Antidepressants in the treatment of depression/depressive symptoms in cancer patients: a systematic review and meta-analysis

Domain

Description

Review author’s judgement

Sequence generation

Describe the method used to generate the allocation sequence

Was the allocation sequence adequately generated? (Yes, No, Unclear)

Allocation concealment

Describe the method used to conceal the allocation sequence

Was allocation adequately concealed? (Yes, No, Unclear)

Blinding of participants, personnel, and outcome

Describe all measures used to blind participants and personnel

Was knowledge of the allocated intervention adequately prevented during the study? (Yes, No, Unclear)

Incomplete outcome data

Describe the completeness of outcome data for each main outcome including attrition and exclusions from the analysis.

Were incomplete outcome data adequately addressed? (Yes, No, Unclear)

Selective outcome reporting

State how the possibility of selective outcome reporting was examined by the review authors and what was found.

Are reports of the study free of suggestion of selective outcome reporting? (Yes, No, Unclear)

Other sources of bias

State any important concerns about bias not addressed in the other domains.

Was the study apparently free of other problems that could put it at high risk of bias?

  1. Study-wise evaluation of Risk of Bias: